Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Biochem Biophys Res Commun ; 385(3): 296-301, 2009 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-19457434

RESUMEN

Is single-strand DNA translatable? Since the 60s, the question still remains whether or not DNA could be directly translated into protein. Some discrepancies in the results were reported about functional translation of single-strand DNA but all results converged on a similar behavior of RNA and ssDNA in the initiation step. Isothermal Titration Calorimetry method was used to determine thermodynamic constants of interaction between single-strand DNA and S30 extract of Escherichia coli. Our results showed that the binding was not affected by the nature of the template tested and the dissociation constants were in the same range when ssDNA (K(d)=3.62+/-2.1 x 10(-8)M) or the RNA corresponding sequence (K(d)=2.7+/-0.82 x 10(-8) M) bearing SD/ATG sequences were used. The binding specificity was confirmed by antibiotic interferences which block the initiation complex formation. These results suggest that the limiting step in translation of ssDNA is the elongation process.


Asunto(s)
Calorimetría/métodos , ADN de Cadena Simple/metabolismo , Iniciación de la Cadena Peptídica Traduccional , Antibacterianos/farmacología , Ácido Aurintricarboxílico/farmacología , Extensión de la Cadena Peptídica de Translación , Iniciación de la Cadena Peptídica Traduccional/efectos de los fármacos , ARN Mensajero/metabolismo , Ribosomas/metabolismo
2.
BMC Cancer ; 7: 220, 2007 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-18047684

RESUMEN

BACKGROUND: RhoB is down-regulated in most lung cancer cell lines and tumor tissues when compared with their normal counterparts. The mechanism of this loss of expression is not yet deciphered. METHODS: Since no mutation has been reported in the RhoB sequence, we investigated the epigenetic regulation of RhoB expression by analyzing the effect of HDAC inhibitors and methyltransferase inhibitors, by direct sequencing after bisulfite treatment and by methylation specific PCR. RESULTS: We first showed that histone deacetylase (HDAC) inhibitors induce a significant RhoB re-expression in lung cancer cell lines whereas only a slight effect was observed with methyl transferase inhibitors. As promoter methylation is the most common epigenetic process in lung cancer, we performed methylation specific PCR and sequence analysis after bisulfite treatment and demonstrated that RhoB was methylated neither in lung cancer cell lines nor in tumor tissues. We also showed that a variable number of tandem repeats sequences in the 5' region of the RhoB gene was involved in HDAC response. CONCLUSION: We thus propose that RhoB regulation of expression occurs mainly by histone deacetylation rather than by promoter hypermethylation and that this process can be modulated by specific 5' sequences within the promoter.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/genética , Epigénesis Genética , Regulación Neoplásica de la Expresión Génica , Neoplasias Pulmonares/genética , Proteína de Unión al GTP rhoB/biosíntesis , Azacitidina/análogos & derivados , Azacitidina/farmacología , Secuencia de Bases , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/patología , Línea Celular Tumoral/química , Línea Celular Tumoral/metabolismo , Línea Celular Tumoral/patología , ADN (Citosina-5-)-Metiltransferasas/antagonistas & inhibidores , Metilación de ADN , Regulación hacia Abajo , Inhibidores Enzimáticos/farmacología , Expresión Génica , Silenciador del Gen , Inhibidores de Histona Desacetilasas , Humanos , Immunoblotting , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Regiones Promotoras Genéticas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sulfitos , Secuencias Repetidas en Tándem , Proteína de Unión al GTP rhoB/genética
3.
EMBO Mol Med ; 9(2): 238-250, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-28003335

RESUMEN

Although lung cancer patients harboring EGFR mutations benefit from treatment with EGFR-tyrosine kinase inhibitors (EGFR-TKI), most of them rapidly relapse. RHOB GTPase is a critical player in both lung carcinogenesis and the EGFR signaling pathway; therefore, we hypothesized that it could play a role in the response to EGFR-TKI In a series of samples from EGFR-mutated patients, we found that low RHOB expression correlated with a good response to EGFR-TKI treatment while a poor response correlated with high RHOB expression (15.3 versus 5.6 months of progression-free survival). Moreover, a better response to EGFR-TKI was associated with low RHOB levels in a panel of lung tumor cell lines and in a lung-specific tetracycline-inducible EGFRL858R transgenic mouse model. High RHOB expression was also found to prevent erlotinib-induced AKT inhibition in vitro and in vivo Furthermore, a combination of the new-generation AKT inhibitor G594 with erlotinib induced tumor cell death in vitro and tumor regression in vivo in RHOB-positive cells. Our results support a role for RHOB/AKT signaling in the resistance to EGFR-TKI and propose RHOB as a potential predictor of patient response to EGFR-TKI treatment.


Asunto(s)
Antineoplásicos/farmacología , Carcinoma de Pulmón de Células no Pequeñas/fisiopatología , Resistencia a Medicamentos , Receptores ErbB/genética , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteína de Unión al GTP rhoB/metabolismo , Animales , Inhibidores Enzimáticos/farmacología , Humanos , Ratones , Ratones Transgénicos , Proteínas Tirosina Quinasas/antagonistas & inhibidores
4.
J Mol Biol ; 344(5): 1409-20, 2004 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-15561152

RESUMEN

A newly defined family of fungal lectins displays no significant sequence similarity to any protein in the databases. These proteins, made of about 140 amino acid residues, have sequence identities ranging from 38% to 65% and share binding specificity to N-acetyl galactosamine. One member of this family, the lectin XCL from Xerocomus chrysenteron, induces drastic changes in the actin cytoskeleton after sugar binding at the cell surface and internalization, and has potent insecticidal activity. The crystal structure of XCL to 1.4 A resolution reveals the architecture of this new lectin family. The fold of the protein is not related to any of the several lectin folds documented so far. Unexpectedly, the structure similarity is significant with actinoporins, a family of pore-forming toxins. The specific structural features and sequence signatures in each protein family suggest a potential sugar binding site in XCL and a possible evolutionary relationship between these proteins. Finally, the tetrameric assembly of XCL reveals a complex network of protomer-protomer interfaces and generates a large, hydrated cavity of 1000 A3, which may become accessible to larger solutes after a small conformational change of the protein.


Asunto(s)
Basidiomycota/química , Lectinas/química , Secuencia de Aminoácidos , Sitios de Unión , Metabolismo de los Hidratos de Carbono , Cristalización , Cristalografía por Rayos X , Lectinas/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Unión Proteica , Conformación Proteica , Alineación de Secuencia , Especificidad por Sustrato
5.
Eur J Cell Biol ; 82(10): 515-22, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14629119

RESUMEN

The lectin isolated from Xerocomus chrysenteron (XCL) displays a toxic activity towards insects. In order to assess its possible mode of action and to gather useful data for its potential use in insect-resistant transgenic plants, we investigated the effects of XCL at the cellular level. Immunofluorescence microscopy studies revealed that XCL is rapidly internalized into small endocytic vesicles that further coalesce in the perinuclear region. We show that XCL is endocytosed by the clathrin-dependent pathway, and is delivered to late endosome/lysosome compartments. The internalization of XCL seems to be general since it occurs in different cell types such as insect (SF9) or mammalian (NIH-3T3 and Hela) cell lines. In the presence of XCL, the uptake of GFP and BSA is greatly enhanced, demonstrating that XCL facilitates endocytosis. Thus, XCL could serve as a delivery agent to facilitate the endocytosis of proteins that do not enter the cell alone.


Asunto(s)
Clatrina/metabolismo , Endocitosis/fisiología , Hongos/metabolismo , Lectinas/metabolismo , Animales , Antifúngicos/farmacología , Línea Celular , Clorpromazina/farmacología , Vesículas Cubiertas por Clatrina/metabolismo , Endosomas/metabolismo , Filipina/farmacología , Hongos/efectos de los fármacos , Proteínas Fluorescentes Verdes , Humanos , Lectinas/genética , Proteínas Luminiscentes , Lisosomas/metabolismo , Potasio/metabolismo , Transporte de Proteínas/fisiología
6.
Mol Cell Biochem ; 258(1-2): 49-55, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15030169

RESUMEN

Lectins are carbohydrate-binding proteins which potentially link to cell surface glycoconjugates and affect cell proliferation. We investigated the effect of a new lectin from the mushroom Xerocomus chrysenteron (XCL) on cell proliferation using adherent and suspension cell lines. XCL caused a dose-dependent inhibition of proliferation of the adherent cell lines NIH-3T3 and HeLa. Several experiments suggest that disruption of cell-substrate adhesion is the main factor affecting cell growth inhibition. (i) No antiproliferative effect was observed on the SF9 cell line, which does not require to be attached to grow. (ii) XCL was shown to affect the adherence of cells following their suspension by trypsin treatment. (iii) XCL was localized on the cell surface where it would act as a coating agent. (iv) XCL induced morphological changes from well spread to rounded cells and disrupted the actin cytoskeleton. By contrast, flow cytometric analysis showed that XCL does not interfere with the cell cycle, and does not induce apoptosis.


Asunto(s)
Basidiomycota/química , Lectinas/farmacología , Citoesqueleto de Actina/metabolismo , Animales , Basidiomycota/genética , Adhesión Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Línea Celular , Membrana Celular/metabolismo , Citoesqueleto/efectos de los fármacos , Glicoconjugados/metabolismo , Humanos , Lectinas/genética , Ratones , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA